Xencor, Inc. Profile Avatar - Palmy Investing

Xencor, Inc.

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that tar…

Biotechnology
US, Monrovia [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Xencor, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Xencor, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Xencor, Inc..

End of XNCR's Analysis
CIK: 1326732 CUSIP: 98401F105 ISIN: US98401F1057 LEI: - UEI: -
Secondary Listings
XNCR has no secondary listings inside our databases.